Minicircles are a new form of supercoiled DNA molecule for nonviral gene tr
ansfer which have neither bacterial origin of replication nor antibiotic re
sistance marker. They are thus smaller and potentially safer than the stand
ard plasmids currently used in gene therapy. They were obtained in E. coli
by att site-specific recombination mediated by the phage lambda integrase,
which was used to excise the expression cassette from the unwanted plasmid
sequences. We produced two minicircles containing the luciferase or beta-ga
lactosidase gene under the control of the strong human cytomegalovirus imme
diate-early enhancer/promoter. Comparing maximal differences, these minicir
cles gave 2.5 to 5.5 times more reporter gene activity than the unrecombine
d plasmid in the NIH3T3 cell line and rabbit smooth muscle cells. Moreover,
injection in vivo into mouse cranial tibial muscle, or human head and neck
carcinoma grafted in nude mice resulted in 13 to 50 times more reporter ge
ne expression with minicircles than with the unrecombined plasmid or larger
plasmids. Histological analysis in muscle showed there were more transfect
ed myofibers with minicircles than with unrecombined plasmid.